Intranasal Drug Delivery Market Size, Share, Trends, Growth and Forecast 2032

Intranasal Drug Delivery Market Insights

According to the report published by Zion Market Research, the global Intranasal Drug Delivery Market size was valued at USD 1.65 Billion in 2023 and is predicted to reach USD 5.12 Billion by the end of 2032. The market is expected to grow with a CAGR of 13.4% during the forecast period. The report analyzes the global Intranasal Drug Delivery Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Intranasal Drug Delivery industry.

Request Free Sample

Global Intranasal Drug Delivery Market: Overview

Drug delivery mainly refers to a method of delivering a drug/medicine into the body to have an effective therapeutic effect. Various methods are majorly utilized for the delivery of the drug. Pulmonary and nasal routes are considered to be the most popular types for delivering the drug.

Global Intranasal Drug Delivery Market: Growth Factors

High prevalence of cardiovascular diseases, patent expiration of popular drugs, increased cases of cancer and diabetes, implementation of self-administration practices, increased focus on pediatric and elderly patients, and rising demand for home healthcare devices are some of the most important aspects propelling the intranasal drug delivery systems market expansion across the world. Other aspects that are expected to fuel this market comprise rapid R&D and acceptance of new drug delivery methods and devices, reformulation of injections and oral drugs into the formulations to be checked by nasal route, and fast onset of action. The global intranasal drug delivery market is projected to increase at a major rate owing to growing R&D in the field and the high implementation rate for delivery mode. Furthermore, enhancement in the reimbursement situation is fuelling the global intranasal drug delivery market.

On the other hand, drug formulation stoppage and market recalls, as well as technical obstruction may act as a restraint to the development of this market. Moreover, high price involved and lack of expert medical professionals are also few of the most important aspects that are restraining the global intranasal drug delivery market.

Request Free Sample

Global Intranasal Drug Delivery Market: Segmentation

In terms of device type, the intranasal drug delivery market can be categorized into ointments & solutions and nasal sprays.

In terms of therapeutic applications, the intranasal drug delivery market can be fragmented into allergic infections, analgesic, osteoporosis, pain management, vaccines, and sexual dysfunction.

Intranasal Drug Delivery Market: Report Scope

Global Intranasal Drug Delivery Market: Regional Analysis

North America is expected to dominate and lead the global intranasal drug delivery market owing to growing implementation of nasal form for delivering the drug as well as better healthcare facilities in the province. In addition, several government initiatives and rise in the awareness rate among the individuals are some of the significant aspects fuelling the global intranasal drug delivery market. The Asia Pacific is likely to be followed by Europe. India and China are projected to be the fastest developing market for intranasal drug delivery in the Asia Pacific. This is owing to the huge investments made by different key companies in these regions. Some of the significant driving factors for the global intranasal drug delivery market in up-coming countries are the huge pool of patients, increasing government funding, and development in the medical facilities.

Global Intranasal Drug Delivery Market: Competitive Players

Some of the most important market players in the global intranasal drug delivery market are:

• Alza Corporation
• Aegis Therapeutics LLC
• MedImmune, Inc.
• AstraZeneca Plc.
• Becton
• Dickinson and Company
• Baxter International, Inc.
• Johnson & Johnson, Inc.
• GlaxoSmithKline Plc.
• Merck & Co.
• Marina Biotech, Inc.
• Pfizer Inc.
• Rexam Plc.
• Valeant Pharmaceuticals International, Inc.
• Novartis AG, among others.

The Global Intranasal Drug Delivery Market is segmented as follows:
 
By device type 

• ointments & solutions 
• nasal sprays

By therapeutic applications 

• allergic infections
• analgesic
• osteoporosis
• pain management
• vaccines
• sexual dysfunction 

Global Intranasal Drug Delivery Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • The UK
  • France
  • Germany
• The Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.